West Pharmaceutical secures $950 million credit agreement with Bank of America-led lenders
Bitget2026/10/26 21:16- West Pharmaceutical Services entered a USD 950 million credit agreement on October 26, 2026, with Bank of America as administrative agent.
- The five-year, unsecured financing comprises a USD 750 million revolving credit facility and a USD 200 million term loan facility.
- Proceeds repaid USD 130 million outstanding under the 2019 credit agreement, which was terminated without early termination penalties.
- Remaining borrowings are intended for general corporate purposes, including capital expenditures, permitted acquisitions and stock repurchases.
- The agreement caps net leverage at 3.50 times, rising to 4.00 times during material acquisition periods, subject to limitations.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Astera Labs (ALAB.US) Q3 earnings and guidance exceed expectations; Scorpio rises to become the top revenue-generating product line
Astera Labs (ALAB.US) released its Q3 2026 financial report after the US stock market closed on November 3.
Surged after hours! Arista Networks (ANET.US) achieved record revenue and profit growth in Q3, with Q4 performance guidance exceeding expectations
Arista Networks released its financial results for the third quarter of 2026 ending September 30.
The US strengthens the dollar on midterm election day, rising Treasury yields provide support, and the US-Iran situation may dominate future market trends.
The US dollar strengthened on Tuesday during the US midterm elections, supported by rising US Treasury yields and robust economic data.
Crypto prices
More
